Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence von Vu, Tuan, Wiendl, Heinz, Katsuno, Masahisa, Reddel, Stephen W, Howard, Jr, James F

Volltext

Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis von Masi, Gianvito, Pham, Minh C., Karatz, Tabitha, Oh, Sangwook, Payne, Aimee S., Nowak, Richard J., Howard, James F., Guptill, Jeffrey T., Juel, Vern C., O'Connor, Kevin C.

Volltext

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase... von Granit, Volkan, Benatar, Michael, Kurtoglu, Metin, Miljković, Miloš D, Chahin, Nizar, Sahagian, Gregory, Feinberg, Marc H, Slansky, Adam, Vu, Tuan, Jewell, Christopher M, Singer, Michael S, Kalayoglu, Murat V, Howard, James F, Mozaffar, Tahseen, Granit, Volkan, Benatar, Michael, Mozaffar, Tahseen, Chahin, Nizar, Howard, James F., Slansky, Adam D., Feinberg, Marc H., Sahagian, Gregory, Vu, Tuan, Pereira, Denise, Steele, Julie, Paredes, Maria Elena, Benjamin, Cara, Komanduri, Krishna, Habib, Ali Aamer, Fong, Julia Kimberly, De La Cruz, Luis, Dimitrova, Diana, Chopra, Manisha, Holley, Kelly, DeMaria, Gabrielle, Tenorio, April, Requena, Naraly, Brooks, Beverly Mackanzie, Suresh, Niraja, Farias, Jerrica, Miljković, Miloš D, Kurtoglu, Metin, Ngo Casi, Minhtran, Chowdhury, Adam, Kamboh, Hafsa, Stewart, C Andrew, Tosun, Mehmet, Shan, Yufei, Daniel, Shaji, Duvernay, Matthew T., Kireeva, Maria, English, Emily, Jewell, Christopher M., Singer, Michael S, Kalayoglu, Murat V

Volltext

Complement Inhibitor Therapy for Myasthenia Gravis von Albazli, Khaled, Kaminski, Henry J., Howard, Jr James F.

Volltext

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis von Howard Jr, James F., Barohn, Richard J., Cutter, Gary R., Freimer, Miriam, Juel, Vern C., Mozaffar, Tahseen, Mellion, Michelle L., Benatar, Michael G., Farrugia, Maria Elena, Wang, Jing Jing, Malhotra, Suneil S., Kissel, John T.

Volltext

Improvement of fatigue in generalised myasthenia gravis with zilucoplan von Weiss, Michael D., Freimer, Miriam, Leite, M. Isabel, Maniaol, Angelina, Utsugisawa, Kimiaki, Bloemers, Jos, Boroojerdi, Babak, Howard, Emily, Savic, Natasa, Howard, James F.

Volltext

Time to response with ravulizumab, a long‐acting terminal complement inhibitor, in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis von Habib, Ali A., Benatar, Michael, Vu, Tuan, Meisel, Andreas, Attarian, Shahram, Katsuno, Masahisa, Liao, Serena, Beasley, Kathleen N., Howard, James F.

Volltext

Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study von Howard, James F., Vu, Tuan, Mantegazza, Renato, Kushlaf, Hani, Suzuki, Shigeaki, Wiendl, Heinz, Beasley, Kathleen N., Liao, Serena, Meisel, Andreas

Volltext

Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study... von Howard, James F., Vu, Tuan, Li, George, Korobko, Denis, Smilowski, Marek, Liu, Li, Gistelinck, Fien, Steeland, Sophie, Noukens, Jan, Van Hoorick, Benjamin, Podhorna, Jana, Borgions, Filip, Li, Yuebing, Utsugisawa, Kimiaki, Wiendl, Heinz, De Bleecker, Jan L., Mantegazza, Renato

Volltext

Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study von Bril, Vera, Howard, James F., Karam, Chafic, De Bleecker, Jan L., Murai, Hiroyuki, Utsugisawa, Kimiaki, Ulrichts, Peter, Brauer, Edward, Zhao, Sihui, Mantegazza, Renato, Vu, Tuan

Volltext

Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment von Allard, Denise E, Wang, Yan, Li, Jian Joel, Conley, Bridget, Xu, Erin W, Sailer, David, Kimpston, Caellaigh, Notini, Rebecca, Smith, Collin-Jamal, Koseoglu, Emel, Starmer, Joshua, Zeng, Xiaopei L, Howard, Jr, James F, Hoke, Ahmet, Scherer, Steven S, Su, Maureen A

Volltext

The Relationship between Trans-Lesional Conduction, Motor Neuron Pool Excitability, and Motor Function in Dogs with Incomplete Recovery from Severe Spinal Cord Injury von Lewis, Melissa J, Howard, Jr, James F, Olby, Natasha J

Volltext

Racial and Ethnic Differences in Timing of Diagnosis and Clinical Services Received in Duchenne Muscular Dystrophy von Mann, Joshua R., Zhang, Yanan, McDermott, Suzanne, Wang, Yinding, Cai, Bo, Conway, Kristin M., Paramsothy, Pangaja, Royer, Julie, Venkatesh, Swamy, Howard Jr, James F., Ciafaloni, Emma

Volltext

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis von Howard, Jr, James F, Bril, Vera, Vu, Tuan, Karam, Chafic, Peric, Stojan, De Bleecker, Jan L, Murai, Hiroyuki, Meisel, Andreas, Beydoun, Said R, Pasnoor, Mamatha, Guglietta, Antonio, Van Hoorick, Benjamin, Steeland, Sophie, T'joen, Caroline, Utsugisawa, Kimiaki, Verschuuren, Jan, Mantegazza, Renato

Volltext

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis von Vu, Tuan, Meisel, Andreas, Mantegazza, Renato, Annane, Djillali, Katsuno, Masahisa, Aguzzi, Rasha, Enayetallah, Ahmed, Beasley, Kathleen N., Rampal, Nishi, Howard, James F.

Volltext

The effect of sacral neuromodulation on pudendal nerve function and female sexual function von Parnell, Brent A., Howard Jr, James F., Geller, Elizabeth J.

Volltext

Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies von Kornegay, Joe N, Bogan, Janet R, Bogan, Daniel J, Childers, Martin K, Li, Juan, Nghiem, Peter, Detwiler, David A, Larsen, C. Aaron, Grange, Robert W, Bhavaraju-Sanka, Ratna K, Tou, Sandra, Keene, Bruce P, Howard, James F., Jr, Wang, Jiahui, Fan, Zheng, Schatzberg, Scott J, Styner, Martin A, Flanigan, Kevin M, Xiao, Xiao, Hoffman, Eric P

Volltext

Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis von de la Borderie, Guillemette, Chimits, Damien, Boroojerdi, Babak, Brock, Melissa, Duda, Petra W, Grimson, Fiona, Mahoney, Paul, Strimenopoulou, Foteini, Cutter, Gary, Aban, Inmaculada, Brauner, Susanna, Petersson, Malin, Howard, Jr, James F, Bennett, Nathan

Volltext

Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses von Howard, James F., Karam, Chafic, Yountz, Marcus, O’Brien, Fanny L., Mozaffar, Tahseen

Volltext

Late-onset Becker muscular dystrophy: Refining the clinical features and electrophysiological findings von Beltran Papsdorf, Tania, Howard Jr, James F., Chahin, Nizar

Volltext